alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
21t 30°77 200

Janior Strength

28
Non-Aspirin
acstaminophen chewable tablets
+ pain evlivwer « fever reducer

* for ages 6-[2

Sott Chenabte Tabl

Fruit Flavor "

vuspion fier

+ iheprolen free bi

r+]
3
mn
z
o
34
zx
hail
a
m
Zz
i]



160 MiG



eaaigo Com pany

Exhtbits
G12 3121


PAIN, RELIEVER

SE ox

BOO pwisvie RELEASE
ASPIRLY TALLSTS

Aaa ARIE Anche mee =

yuan rs rene rat qapan a 0m woo PrareeiOn
COMING 3 6 RS NLA: OAS BME AGH TOR IETHER

Sitbiyeiamen caren reutnianse CES AMEN Was CREP STEAM LAC

(AUR ATERUETN RELATE OC NaN TT PEAT MC IE NMS CR DM UFO

seer Faas i tas su sa a ae Te Ba
‘Tae ewmenic er sca) TO 4 LOL THE Teakel TO Pass WeyKzaH Tee
SGI iulne Weer SaRe MoSSrLiee Repos ns La WaukoT Sora

a
Til ERAOECT WILL MOT PROVING FAST RELIEF OF HRADALHES. aki

ENTE ETVLATED NONCALYSERIS, COLL AMAL SIUOE
Geta dss sigmnate wn)

QAGUne SR SE|ONTE. BET
SLRIUAL OUL eLLDW AT re
Tibagaiete Th Uke

in
TaRULCe MInGTAL BIL GOE

We rE ULES.
PRUSERAATE £0, TTT DIDSICE

caw HLA
“Hc PUTERIZ COATE GAG onureuin on DEMMELTED BY AR CCAHTE ION

any
Oe ce arenes Muy ceo Sei HAE

wen yFReTIN2 BY P: Yrk7o [eee tae
rouenaeenesoca. BES ie” [iameaceme|

Hye mpm nee

Woe o195-F808-67

Cooymire to Rayer* Adit
Low Streauith Aspirin active ingrextiests?


eg weet: rt ent pecan

0

cine bens Cdk i De Va
‘Sard, DAS tela #10 AUT

Auminun’ is, Fost.
Hyder

Bult, Soda Seach Cyraide, Tanti Letede.
Ear tem rae. ch oes
acter
caneaed
Toy, Michigen ABO

‘Hygu aro nol sang wah cis
becniaecer atria “

Hivaen cal! 1-004

IBUPROFEN TABLETS, clan Dugrafey sat AND Bec] A reer wtwos Nae Daan
press by ks fo ails ad & apa ara TCM ST Mp

rata) Modern Pain Medicine _ sr bsheearreld

4 eee

eenhin vitor hase
Exhibit 10.8

 

Power of Attorney

 

THIS POWER OF ATTORNEY (hereinafter, the “Power of Attorney”) is executed by Zuyu DING (Domicile [*], ID card No.: [*]) as of September 10, 2011 and issued to Xin ZHOU (Domicile [*], ID card No.: [*]) (hereinafter, the “Entrusted Person”).

 

I, Zuyu DING, hereby entrust the Entrusted Person with full representative power to exercise the following rights owned by me in the capacity of a shareholder of Beijing Yisheng Leju Information Services Co., Ltd. (hereinafter, the “Company”) on my behalf:

 

(1)              As my representative, to propose to convene and attend shareholders’ meetings of the Company according to the articles of association of the Company;

 

(2)              As my representative, to exercise, on my behalf, voting rights on all matters requiring discussion or resolutions of the shareholders’ meetings of the Company, including without limitation, the appointment and election of the Company’s directors and other officers, who should be appointed and removed by the shareholders;

 

(3)              As my representative, to exercise other voting rights of a shareholder as specified in the articles of association of the Company (including any other shareholder voting rights as specified in the amended articles of association).

 

I hereby irrevocably confirm that this Power of Attorney shall continue to be valid until the Shareholder Voting Right Proxy Agreement executed by and between Shanghai SINA Leju Information Technology Co., Ltd. (hereinafter, the “WFOE”), the Company and the shareholders of the Company as of September 10, 2011 expires or is early terminated, unless the WFOE gives me a direction to replace the Entrusted Person.

 

Authorization is hereby made.

 

	
 
    	
Name:  Zuyu DING
    
	
 
    	
Signature:
    	
/s/ Zuyu DING
    
	
 
    	
Date: September 10, 2011
Exhibit 23.4





CONSENT OF QUALIFIED PERSON





I, Marco Fazzi, state that I am responsible for preparing or supervising the preparation of part(s) of the technical report summary titled "Technical Report Summary, Operation Report, Nueva Victoria" with an effective date of April 5, 2024, as signed, and certified by me (the “Technical Report Summary”).





Furthermore, I state that:





a. I consent to the public filing of the Technical Report Summary by Sociedad Química y Minera de Chile S.A. (the “Company”) as an exhibit to Form 6-K of the Company (“Form 6-K”);





b. the document that the Technical Report Summary supports is the Company’s Annual Report on Form 20-F for the year ended December 31, 2023, and any existing amendments or supplements and/or exhibits thereto (the "Form 20-F") (the Form 6-K and Form 20-F, collectively the “Document”);





c. I consent to the use of my name in the Document, to any quotation from or summarization in the Document of the parts of the Technical Report Summary for which I am responsible, and to the incorporation by reference of the Technical Report Summary into Form 20-F; and





d. I confirm that I have read the Document, and that the Document fairly and accurately reflects, in the form and context in which it appears, the information in the parts of the Technical Report Summary for which I am responsible.





By/s/ Marco FazziMarco FazziMineral Resources and Long-Term Planning ManagerSQM





Dated at Santiago, Chile on April 5, 2024
Exhibit 12.1


STATEMENT RE COMPUTATION OF RATIOS

This schedule  contains  financial  information  extracted from the Registrant's
Financial Statements as of March 31, 2002 and December 31, 2001 and is qualified
in its entirety by reference to such Financial Statements:

<TABLE>
<CAPTION>
                                                                             March 31,        December 31,
                                                                               2002                2001
                                                                           -------------    ----------------
Current Ratio:
<S>                                                                           <C>                 <C>

The ratio of current assets divided by current liabilities -

Current assets  (numerator)                                                   $784,789            $510,406
Current liabilities (denominator)                                              600,323             364,909

   Current ratio                                                                   1.3                 1.4

Working Capital:

Current Assets minus Current Liabilities

Current assets                                                                $784,789            $510,406
Current liabilities                                                            600,323             364,909

   Working Capital                                                             184,466             145,497

</TABLE>
Arkanova Energy Corporation - Exhibit 10.6 - Filed by newsfilecorp.com






AMENDMENT TO EXECUTIVE EMPLOYMENT AGREEMENT 

THIS AGREEMENT made the 1st day of March, 2014. 

BETWEEN: 


  
    
      
        ARKANOVA ENERGY CORPORATION, a Nevada corporation 

        (the “Company”) 

      

    

  



AND: 


  
    
      
        PIERRE MULACEK, an  individual

        (the “Executive”) 

      

    

  



WHEREAS: 

A.          The
Company and the Executive entered into an Employment Agreement, dated July 17,
2012 (the “Employment Agreement”), pursuant to which the Executive and
the Company agreed to pay the Executive a salary of US $240,000 per annum; 

B.          The
Company and the Executive have agreed to decrease the annual compensation
payable to the Executive from US $240,000 per annum to US $135,000 per annum,
which decrease is effective on March 1, 2014; and 

C.          The Company
and the Executive have agreed to amend the terms of the Employment Agreement to
decrease the compensation payable to the Executive to US $135,000 per annum.


NOW THEREFORE THIS AGREEMENT witnesses that, for good and
valuable consideration, the receipt and sufficiency of which is hereby
acknowledged, the parties hereto agree as follows: 

	1. 	
      Section 8(a) of the Employment Agreement is deleted and
      replaced with the following:





	(a) 	
      As compensation for the services provided by the
      Executive under this Agreement, the Company will pay the Executive an
      annual salary of $135,000.00, to be paid in accordance with the Company's
      usual payroll procedures (the
“Salary”).





	2. 	
      The Company and the Executive each acknowledge and agree
      that all other provisions of the Employment Agreement remain in full force
      and effect.







- 2 - 

	3. 	
      This Agreement may be executed in counterpart and such
      counterparts together shall constitute a single instrument. Delivery of an
      executed counterpart of this Agreement by electronic means, including by
      facsimile transmission or by electronic delivery in portable document
      format (“.pdf”), shall be equally effective as delivery of a manually
      executed counterpart hereof. The Parties acknowledge and agree that in any
      legal proceedings between them respecting or in any way relating to this
      Agreement, each waives the right to raise any defense based on the
      execution hereof in counterparts or the delivery of such executed
      counterparts by electronic means.

	 	 
	4. 	
      This Agreement will be governed by and construed in
      accordance with the law of Texas.



IN WITNESS WHEREOF, the parties have executed and delivered
this Agreement as of the date first written above. 

ARKANOVA ENERGY CORPORATION 

 

	Per: 	/s/ Reginald Denny 	 
	  	Authorized Signatory 	 



 

	/s/ Pierre
      Mulacek 	 
	PIERRE G. MULACEK
#### Minnie FISHER, Appellant, v. W. S. WIGHTMAN, as administrator c. t. a. of the Estate of Russel Fisher, Deceased, Appellee.

No. 68-338.

District Court of Appeal of Florida, Second District.

March 25, 1971.

Appeal dismissed.
**EXHIBIT 31.2**

 

**SARBANES-OXLEYSECTION 302 CERTIFICATION**

###### **CERTIFICATION OF VERITAS DGC INC.**

 

I, Mark E.Baldwin, the Chief Financial Officer, certify that:

 

1.                    Ihave reviewed this quarterly report on Form 10-Q of Veritas DGCInc.;

 

2.                    Based on my knowledge, this report doesnot contain any untrue statement of a material fact or omit to state a materialfact necessary to make the statements made, in light of the circumstances underwhich such statements were made, not misleading with respect to the period coveredby this report;

 

3.                    Based on my knowledge, the financialstatements, and other financial information included in this report, fairlypresent in all material respects the financial condition, results of operationsand cash flows of the registrant as of, and for, the periods presented in thisreport;

 

4.                    Theregistrant’s other certifying officer(s) and I are responsible for establishingand maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and15d-15(e)) for the registrant and have:

 

a)              Designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision,  to ensure that material information relatingto the registrant, including its consolidated subsidiaries, is made known to usby others within those entities, particularly during the period in which thisreport is being prepared;

 

b)             Evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

 

c)              Disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

 

5.                    The registrant’s other certifyingofficer(s) and I have disclosed, based on our most recent evaluation ofinternal control over financial reporting, to the registrant’s auditors and theaudit committee of registrant’s board of directors (or persons performing theequivalent functions):

 

a)              Allsignificant deficiencies and material weaknesses in the design or operation ofinternal controls over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and

 

b)             Anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal controls over financialreporting.

 

June 17, 2005
|   | /s/  MARK E. BALDWIN     |   |
|--------|--------------------------|--------|
|   | Mark  E. Baldwin         |   |
|   | Chief  Financial Officer |   |

 

----
Exhibit 31.2
**CERTIFICATION**
I, Christine G. Ocampo, certify that:
 1. I have reviewed this Annual Report on Form 10-K of CardioGenesisCorporation;  2. Based on my knowledge, this Annual Report does not contain any untruestatement of a material fact or omit to state a material fact necessaryto make the statements made, in light of the circumstances under whichsuch statements were made, not misleading with respect to the periodcovered by this Annual Report;  3. Based on my knowledge, the financial statements, and other financialinformation included in this Annual Report, fairly present in allmaterial respects the financial condition, results of operations andcash flows of the registrant as of, and for, the periods presented inthis Annual Report;  4. The registrant’s other certifying officer and I are responsible forestablishing and maintaining disclosure controls and procedures (asdefined in Exchange Act Rules 13a-15(e) and 15d-15(e) for the registrantand we have:
(a) designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under our supervision,to ensure that material information relating to the registrant, includingits consolidated subsidiaries, is made known to us by others within thoseentities, particularly during the period in which this Annual Report isbeing prepared;
(b) evaluated the effectiveness of the registrant’s disclosure controlsand procedures and presented in this report our conclusions about theeffectiveness of the disclosure controls and procedures, as of the end ofthe period covered by this Annual Report based on such evaluation; and
(c) disclosed in this report any change in the registrant’s internalcontrol over financial reporting that occurred during the registrant’smost recent fiscal quarter that has materially affected, or is reasonablylikely to materially affect, the registrant’s internal control overfinancial reporting; and
 5. The registrant’s other certifying officer and I have disclosed, basedon our most recent evaluation of internal control over financialreporting, to the registrant’s auditors and the audit committee of theregistrant’s board of directors:
(a) all significant deficiencies and material weaknesses in the design oroperation of internal control over financial reporting which arereasonably likely to adversely affect the registrant’s ability to record,process, summarize and report financial information; and
(b) any fraud, whether or not material, that involves management or otheremployees who have a significant role in the registrant’s internal controlover financial reporting.
/s/ CHRISTINE G. OCAMPO
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 01-1991

ESTHER DAFF, widow of Harold Daff,

Petitioner,

versus

DIRECTOR, OFFICE OF WORKERS’ COMPENSATION

PROGRAMS, UNITED STATES DEPARTMENT OF LABOR,

Respondent.

On Petition for Review of an Order of the Benefits Review Board.

(00-0568-BLA)

Submitted: January 17, 2002 Decided: January 25, 2002

Before WILKINS and KING, Circuit Judges, and HAMILTON, Senior

Circuit Judge.

Affirmed by unpublished per curiam opinion.

Esther Daff, Petitioner Pro Se. Patricia May Nece, Christian P.

Barber, Helen Hart Cox, UNITED STATES DEPARTMENT OF LABOR,

Washington, D.C., for Respondent.

Unpublished opinions are not binding precedent in this circuit.

See Local Rule 36(c).
2

PER CURIAM:

Esther Daff seeks review of the Benefits Review Board’s

decision and order affirming the administrative law judge’s denial

of black lung benefits pursuant to 30 U.S.C.A. §§ 901-945 (West

1986 & Supp. 2001). Our review of the record discloses that the

Board’s decision is based upon substantial evidence and is without

reversible error. Accordingly, we affirm on the reasoning of the

Board. See Daff v. Director, Office of Workers’ Comp. Programs,

No. 00-568-BLA (BRB Mar. 30, 3001). We dispense with oral argument

because the facts and legal contentions are adequately presented in

the materials before the court and argument would not aid the

decisional process.

AFFIRMED
#### Pamela K. FACENTE, Appellant, v. James T. FACENTE, Appellee.

No. 76-1620.

District Court of Appeal of Florida, Third District.

Sept. 20, 1977.

Ralph F. Miles, Hialeah, for appellant.

McCormick, Bedford & Backmeyer and Gerald L. Bedford, Miami, for appellee.

Before PEARSON, NATHAN and HUB-BART, JJ.

PER CURIAM.

Affirmed. See *Epperson v. Epperson,*101 So.2d 367, 370 (Fla.1958); *Bergh v. Bergh,*127 So.2d 481, 486 (Fla. 1st DCA 1961).
#### William HARVEY, Appellant, v. The STATE of Florida, Appellee.

No. 72-785.

District Court of Appeal of Florida, Third District.

Jan. 29, 1973.

Phillip A. Hubbart, Public Defender and Lewis S. Kimler and Mark King Leban, Asst. Public Defenders, for appellant.

Robert L. Shevin, Atty. Gen. and Arnold R. Ginsberg, Asst. Atty. Gen., for appellee.

Before PEARSON, CHARLES CARROLL and HENDRY, JJ.

HENDRY, Judge.

Appellant seeks review of his convictions for grand larceny and for breaking and entering a dwelling.

*101We have considered the record, briefs and arguments of counsel in light of the controlling principles of law and have concluded that no reversible error has been demonstrated as to appellant’s conviction for grand larceny. Thus, as to that conviction we affirm.

However, the appellant has noted, and the state has conceded, that insufficient evidence appears of record to sustain a conviction for *breaking*and entering. Thus, pursuant to § 924.34, Fla.Stat., F.S. A.,1 we reverse the conviction as to breaking and entering and direct the trial court to enter judgment for the offense of entering without breaking, pursuant to § 810.03, Fla.Stat., F.S.A.

Affirmed in part, reversed in part.

1

. Fla.Stat., § 924.34, F.S.A., provides:

> “When evidence sustains only conviction of lesser offense. — When the appellate court determines that the evidence does not prove the offense for which the defendant was found guilty but does establish 1ns guilt of a lesser statutory degree of the offense or a lesser offense necessarily included in the offense charged, the appellate court shall reverse the judgment and direct the trial court to enter judgment for the lessor degree of the offense or for the lesser included offense.”
<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                          22,357
<SECURITIES>                                         0
<RECEIVABLES>                                  140,586
<ALLOWANCES>                                         0
<INVENTORY>                                  5,933,399
<CURRENT-ASSETS>                             6,096,342
<PP&E>                                       5,727,799
<DEPRECIATION>                               3,959,180
<TOTAL-ASSETS>                               8,174,480
<CURRENT-LIABILITIES>                        3,671,998
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                     2,688,605
<OTHER-SE>                                           0
<TOTAL-LIABILITY-AND-EQUITY>                 8,174,480
<SALES>                                      1,579,735
<TOTAL-REVENUES>                             1,700,066
<CGS>                                        1,322,442
<TOTAL-COSTS>                                1,552,108
<OTHER-EXPENSES>                               152,759
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                              76,907
<INCOME-PRETAX>                                147,958
<INCOME-TAX>                                    59,273
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                    88,685
<EPS-BASIC>                                        .03
<EPS-DILUTED>                                      .03


</TABLE>
[Federal Register Volume 62, Number 5 (Wednesday, January 8, 1997)]
[Notices]
[Page 1134]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-431]


-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on October 16, 1996, Pharmacia & 
Upjohn Company, 7000 Portage Road, 2000-41-109 Kalamazoo, Michigan 
49001, made application to the Drug Enforcement Administration (DEA) 
for registration as a bulk manufacturer of 2,5-dimethoxyamphetamine 
(7396) a basic class of controlled substance listed in Schedule I.
    The firm plans to manufacture the controlled substance for 
distribution as bulk product to a customer.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than March 10, 1997.

    Dated: December 17, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 97-431 Filed 1-7-97; 8:45 am]
BILLING CODE 4410-09-M
* Pursuant to 5 TH C IR. R. 47.5, the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR. R. 47.5.4.

### IN THE UNITED STATES COURT OF APPEALS

FOR THE FIFTH CIRCUIT

No. 08-10199 Conference Calendar UNITED STATES OF AMERICA Plaintiff-Appellee v. ALKER DE LA SIERRA Defendant-Appellant

Appeal from the United States District Court for the Northern District of Texas USDC No. 3:07-CR-154-7 Before DAVIS, WIENER, and PRADO, Circuit Judges. PER CURIAM: * The Federal Public Defender appointed to represent Alker De La Sierra has moved for leave towithdrawand has filed a brief in accordance with Anders v. California, 386 U.S. 738 (1967). De La Sierra has not filed a response. Our independent review of the record and counsel’s brief discloses no nonfrivolous issue for appeal. Accordingly, counsel’s motion for leave to withdraw is GRANTED, counsel is excused from further responsibilities herein, and the APPEAL IS DISMISSED. See 5 TH C IR. R. 42.2. United States Court of Appeals Fifth Circuit 

### F I L E D December 10, 2008 Charles R. Fulbruge III Clerk